BioCentury
ARTICLE | Financial News

As resources diversify, Sofinnova Partners stays course with new €333M fund

Sofinnova’s ninth core fund will stick with the French VC’s early stage, company-building approach

October 17, 2019 6:01 AM UTC
Updated on Oct 17, 2019 at 10:52 PM UTC

Although European venture firm Sofinnova Partners isn’t planning major changes for its largest-ever ninth fund, the firm will be investing the new vehicle alongside several other vertically oriented funds Sofinnova has raised to complement its core early stage, company-building approach.

The firm closed Sofinnova Capital IX at €333 million ($366.9 million). The fund is just over 10% larger than its €300 million, 2015-vintage eighth fund and 30% larger than its first pure life sciences fund, 2012’s €240 million Fund VII...

BCIQ Company Profiles

Sofinnova Partners